Evonik Venture Capital, established in 2012, is the corporate venture capital unit of Evonik Industries AG, a global leader in specialty chemicals. With a fund size of €400 million, the firm has made over 50 investments, both direct and fund-based, focusing on early to growth-stage companies. Evonik Venture Capital invests in innovative technologies and disruptive business models in fields such as Nutrition & Care, Specialty Additives, Smart Materials, as well as enabling digital technologies and sustainability. The firm operates globally with offices in Germany, the USA, and China, aiming to generate strategic value and growth opportunities through partnerships with innovative startups.
Is Evonik Venture Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Evonik Venture Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
€5,000,000 - €15,000,000
When engaging Evonik Venture Capital, founders should highlight how their technology or business model can create tangible synergies with a global specialty chemicals leader. Emphasize scalability, clear industrial applications, and the potential for strategic collaboration or co-development. Demonstrating a pathway to market adoption within complex value chains, especially where sustainability and digitalization are key, will resonate with their partnership-driven approach.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.